Human ageing impairs injury-inducedin vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA
- 1 October 1997
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 183 (2) , 169-176
- https://doi.org/10.1002/(sici)1096-9896(199710)183:2<169::aid-path915>3.0.co;2-q
Abstract
Proteolysis is an essential component of wound healing but, if uncontrolled, it may lead to degradation of the neo‐matrix and a delay in wound repair. Despite numerous reports of impaired wound healing associated with increasing age, the control of proteolysis is completely unknown. Tissue inhibitor of matrix metalloproteinases (TIMP)‐1 and ‐2 inhibit the activity of matrix metalloproteinases and the pattern of regulation of these molecules determines in part the spatial and temporal regulation of proteolytic activity. This study reports on TIMP‐1 and ‐2 protein localization using immunocytochemistry in healing wounds of healthy subjects of different ages from day 1 to 6 months post‐wounding, and has quantified the mRNA levels for both inhibitors using reverse transcriptase‐polymerase chain reaction (RT‐PCR). TIMP‐1 and TIMP‐2 proteins are up‐regulated from 24 h post‐wounding, with a decrease in staining intensity by day 7 for TIMP‐2 and by day 14 for TIMP‐1. Steady‐state mRNA levels for both TIMPs were significantly greater in normal young skin than in aged skin. In the young, there was a significant increase in mRNA expression for TIMP‐1 and ‐2 by day 3 post‐wounding, which decreased by day 14 and had returned to basal levels at day 21. In the wounds of the aged subjects, basal levels were observed for TIMP‐1 and ‐2 at all time‐points. These results suggest that intrinsic cutaneous ageing is associated with reduced levels of TIMP mRNA both in normal skin and during acute wound repair. These levels may be instrumental in dermal tissue breakdown in normal skin, retarded wound healing, and the predisposition of the elderly to chronic wound healing states. © 1997 John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- Uncoordinate expressions of type I and III collagens, collagenase and tissue inhibitor of matrix metalloproteinase 1 along in vitro proliferative life span of human skin fibroblastsCell Biology International, 1995
- Tissue Inhibitor of Metalloproteinases (TIMP-1) Stimulates the Secretion of Collagenase from Human Skin FibroblastsBiochemical and Biophysical Research Communications, 1994
- Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferationJournal of Cellular Physiology, 1993
- Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9Journal of Investigative Dermatology, 1993
- Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma.Journal of Clinical Investigation, 1992
- Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblastsGene, 1992
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- A metalloproteinase inhibitor as an inhibitor of neovascularizationJournal of Cellular Biochemistry, 1991
- Growth Stimulation of Human Keratinocytes by Tissue Inhibitor of MetalloproteinasesJournal of Investigative Dermatology, 1991
- Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activityExperimental Cell Research, 1989